Skip to content

Clinical trials

Phase 1/2 Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1/2 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20131
20161
20181
20192
20202
20211
20222
20241
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Not yet recruiting2
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
Adeona Pharmaceuticals1
Friendi.fi Corporation1
MTI Biotech Inc1
Mayo Clinic1
National Institute of Mental Health (NIMH)1
Paul E Schulz1
Perseverance Research Center, LLC1
Posit Science Corporation1
The University of Texas Health Science Center at San Antonio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction22
Alzheimer Disease12
Dementia4
Amyotrophic Lateral Sclerosis1
Autism Spectrum Disorder1
Autistic Disorder1
Chemotherapy-Related Cognitive Impairment1
Cognition Disorders1
Down Syndrome1
Inflammation1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.